“Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland”, Swiss Med Wkly, vol. 137, no. 2122, pp. 317–322, Jun. 2007, doi: 10.4414/smw.2007.11716.